Home 禄 Business 禄 Manufacturing
Drug firm inks deal to build new plant
Source: Xinhua |
June 15, 2011, Wednesday
|
Print Edition
Print Edition
HARBIN Pharmaceutical Group yesterday signed an agreement to build a new production plant following a recent pollution scandal that erupted over its waste emissions.
The agreement was signed with Harbin's Acheng District government.
Zhang Lijun, president and general manager of Harbin Pharmaceutical, apologized for the pollution, which was caused by excess waste emissions of water and gases.
The new plant will meet national standards on emissions, Zhang said.
China Central Television reported earlier this month that the main plant of Harbin Pharmaceutical Group, an antibiotics maker based in Harbin, capital of northeast China's Heilongjiang Province, emitted waste gases and water that exceeded legal limits.
"The odor concentration has been 20 times higher than legal limits for years," said Peng Xu, an inspector at Harbin's environmental protection bureau.
After the CCTV report and ensuing public outrage, Harbin Pharmaceutical decided to build a new plant with improved facilities in Acheng District, a suburb in the provincial capital.
The first phase of the project is scheduled to be completed in 2013 with a planned investment of 2 billion yuan (US$309 million), according to the agreement.
Wu Zhijun, chief of the main plant of Harbin Pharmaceutical, said the new plant's manufacturing technology and pollution control measures would improve significantly.
The existing area of Harbin Pharmaceutical's main plant was built in 1958. It will be used as a research center after the new plant is built.
The agreement was signed with Harbin's Acheng District government.
Zhang Lijun, president and general manager of Harbin Pharmaceutical, apologized for the pollution, which was caused by excess waste emissions of water and gases.
The new plant will meet national standards on emissions, Zhang said.
China Central Television reported earlier this month that the main plant of Harbin Pharmaceutical Group, an antibiotics maker based in Harbin, capital of northeast China's Heilongjiang Province, emitted waste gases and water that exceeded legal limits.
"The odor concentration has been 20 times higher than legal limits for years," said Peng Xu, an inspector at Harbin's environmental protection bureau.
After the CCTV report and ensuing public outrage, Harbin Pharmaceutical decided to build a new plant with improved facilities in Acheng District, a suburb in the provincial capital.
The first phase of the project is scheduled to be completed in 2013 with a planned investment of 2 billion yuan (US$309 million), according to the agreement.
Wu Zhijun, chief of the main plant of Harbin Pharmaceutical, said the new plant's manufacturing technology and pollution control measures would improve significantly.
The existing area of Harbin Pharmaceutical's main plant was built in 1958. It will be used as a research center after the new plant is built.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
